Approval · Notice of Compliance 13023 · 2012
MONICURE: Notice of Compliance 13023
Issued February 10, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13023
- Date
- February 10, 2012
- Company
- Insight Pharmaceuticals LLCTarrytown, New York, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Therapeutic class
- Antifungal Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONICURE | 02378302 | Cancelled Post Market |
Medicinal ingredients
- FLUCONAZOLE 150 MG per CAP